RxElite, Inc. 4
4 · RxElite, Inc. · Filed Jun 26, 2008
Insider Transaction Report
Form 4
RxElite, Inc.RXEI
Sullivan Earl
Chief Operating Officer
Transactions
- Award
Stock Option (Right to buy)
2008-05-02+450,000→ 450,000 totalExercise: $0.28Exp: 2013-05-02→ Common Stock (450,000 underlying) - Award
Stock Option (Right to buy)
2008-05-02+750,000→ 750,000 totalExercise: $0.28Exp: 2018-05-02→ Common Stock (750,000 underlying)
Footnotes (2)
- [F1]These options were granted pursuant to the 2007 Incentive Stock Plan which is subject to stockholder approval.
- [F2]All of the options are subject to vesting and vest in 25% increments beginning on May 2, 2009.